title: [Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker].
authors.affiliation: Audifarma S.A, Pereira, Colombia.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Portilla
authors.affiliation: Audifarma S.A, Pereira, Colombia.
authors.forename: Daniel
authors.initials: D
authors.lastname: Torres
authors.affiliation: Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.
authors.forename: Manuel Enrique
authors.initials: ME
authors.lastname: Machado-Duque
authors.affiliation: Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia. Electronic address: machado@utp.edu.co.
authors.forename: Jorge Enrique
authors.initials: JE
authors.lastname: Machado-Alba
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure; D004359:Drug Therapy, Combination; D006801:Humans; D010818:Practice Patterns, Physicians'
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors